Tandem Diabetes Care, Inc. logo TNDM - Tandem Diabetes Care, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 24
HOLD 15
SELL 0
STRONG
SELL
0
| PRICE TARGET: $31.69 DETAILS
HIGH: $55.00
LOW: $21.00
MEDIAN: $28.00
CONSENSUS: $31.69
UPSIDE: 111.76%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue
Revenue 1,014.7 940.2 747.7 801.2 702.8 498.8 362.3 183.9 107.6 84.2 72.8 49.7 29.0 2.5 0
Cost of Revenue 483.9 450.6 380.0 388.2 326.6 238.3 168.1 94.0 63.5 60.7 46.3 34.5 22.8 3.8 0
Gross Profit 530.8 489.6 367.7 413.0 376.2 260.5 194.2 89.8 44.1 23.6 26.6 15.2 6.2 (1.3) 0
Operating Expenses
R&D Expenses 174.8 198.9 248.4 170.2 92.1 63.6 45.2 29.2 20.7 18.8 17.0 15.8 11.1 9.0 8.3
SG&A Expenses 434.1 389.8 352.5 335.7 261.5 204.9 165.7 105.2 86.4 82.8 78.6 75.1 44.5 22.7 16.0
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 609.0 588.7 600.9 505.8 353.6 268.5 210.9 134.5 107.0 101.6 95.6 90.9 55.6 31.7 24.2
Operating Income
Operating Income (78.1) (99.1) (233.2) (92.8) 22.7 (8.0) (16.7) (44.6) (62.9) (78.1) (69.0) (75.7) (49.4) (33.0) (24.2)
Interest Expense 7.9 7.4 9.9 6.2 6.0 12.8 0.1 7.6 11.3 5.7 3.7 3.9 4.7 2.5 0.5
Interest Income 9.1 18.0 22.9 6.1 0.7 1.6 3.3 1.5 0.2 0.3 0.3 0.1 0.0 0.0 0.0
Profitability
EBITDA (174.7) (99.1) (196.5) (74.2) 34.1 (13.0) (18.5) (109.2) (54.8) (72.3) (63.8) (71.2) (55.3) (28.5) (22.9)
EBIT (192.4) (99.3) (212.2) (88.5) 20.2 (23.5) (24.5) (115.0) (61.7) (77.8) (68.7) (75.6) (58.4) (30.5) (25.0)
Income Before Tax (200.3) (91.9) (220.3) (92.9) 15.9 (36.3) (24.6) (122.6) (73.0) (83.5) (72.4) (79.5) (63.1) (33.0) (25.5)
Income Tax Expense 4.4 4.2 2.4 1.7 0.3 (1.9) 0.1 0.1 0.0 (0.0) 0.0 0.1 4.7 2.5 0
Net Income (204.7) (96.0) (222.6) (94.6) 15.6 (34.4) (24.8) (122.6) (73.0) (83.4) (72.4) (79.5) (63.1) (33.0) (25.5)
Per Share Data
EPS (Basic) -3.04 -1.47 -3.43 -1.47 0.25 -0.56 -0.42 -2.55 -12.86 -27.30 -25.04 -34.17 -27.53 -26.32 -20.34
EPS (Diluted) -3.04 -1.47 -3.43 -1.47 0.24 -0.56 -0.42 -2.55 -12.86 -27.30 -25.04 -34.17 -27.53 -26.32 -20.34
Shares Outstanding 67.3 65.5 64.9 64.1 63 61.0 58.5 48.1 5.7 3.1 2.9 2.3 2.3 1.3 1.3
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 90.6 69.2 58.9 172.5 71.2 94.6 51.2 41.8 13.7 44.7
Short-Term Investments 202.0 369.1 409.0 444.4 552.6 390.3 125.3 87.2 0.5 8.9
Net Receivables 165.5 114.6 105.6 114.7 110.7 82.2 46.6 35.2 20.8 11.2
Inventory 128.8 149.6 157.9 111.1 68.6 63.7 49.1 19.9 27.0 21.2
Other Current Assets 31.2 22.0 16.6 7.2 0 0 0 3.8 2.2 2
Total Current Assets 618.1 724.5 748.0 850.0 811.5 637.2 276.1 187.9 64.2 92.1
Non-Current Assets
Property, Plant & Equipment 179.8 163.5 164.3 179.2 77.9 69.8 48.5 17.2 19.6 18.4
Goodwill 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0.9 2.8 4.6 6.6 8.8 0.8 1.1 1.5 1.8
Long-Term Investments 60.4 74.5 0 0 0 0 0 0 10 0
Other Non-Current Assets 22.9 4.2 37.6 19.0 9.1 0.6 0.7 0.1 10.1 0.1
Total Non-Current Assets 263.0 243.2 204.7 202.8 93.6 79.2 50.0 18.4 31.2 20.3
Total Assets 881.1 967.7 952.7 1,052.8 905.1 716.4 326.1 206.3 95.3 112.4
Current Liabilities
Account Payables 47.1 44.7 49.6 55.7 28.0 17.8 17.7 6.8 5.2 7.5
Short-Term Debt 19.5 40.7 0 0 0 0 0 0 0 0
Deferred Revenue 9.5 11.8 44.0 18.8 10.2 6.1 3.9 4.6 2.5 5.2
Other Current Liabilities 166.7 47.1 71.9 68.0 74.9 65.8 63.4 30.8 13.9 8.6
Total Current Liabilities 242.7 247.0 195.3 165.3 131.9 103.9 99.4 66.3 36.1 31.5
Non-Current Liabilities
Long-Term Debt 425.0 308.3 285.0 283.2 281.5 203.0 0 0 76.5 79.0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 58.2 32.4 31.8 23.9 17.8 27.4 17.7 8.7 11.9 7.9
Total Non-Current Liabilities 483.2 457.5 443.8 447.5 340.2 246.3 31.7 8.7 88.4 86.8
Total Liabilities 725.9 704.6 639.0 612.8 472.0 350.1 131.1 75.0 124.5 118.3
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0
Retained Earnings (1,252.5) (1,047.8) (951.8) (729.2) (634.6) (659.2) (624.8) (600.1) (477.6) (404.6)
Accumulated Other Comprehensive Income 5.6 (1.9) 1.4 (1.8) (0.6) 0.2 0.1 (0.0) 0 (0.0)
Total Stockholders' Equity 155.2 263.1 313.6 439.9 433.1 366.3 195.0 131.3 (29.1) (5.9)
Total Liabilities & Equity 881.1 967.7 952.7 1,052.8 905.1 716.4 326.1 206.3 95.3 112.4
Debt Metrics
Total Debt 444.5 473.6 415.7 419.9 314.7 228.3 20.4 0 76.5 79.0
Net Debt 353.8 404.3 356.8 247.4 243.5 133.7 (30.8) (41.8) 62.8 34.3
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (204.7) (96.0) (222.6) (94.6) 15.6 (34.4) (24.8) (122.6) (73.0) (83.4)
Depreciation & Amortization 13.8 16.6 15.7 14.3 13.8 10.5 6.1 5.8 6.9 5.5
Stock-Based Compensation 92.4 101.4 88.1 84.9 60.8 58.4 58.1 23.7 12.6 11.7
Change in Working Capital (23.0) (11.8) (17.7) (4.6) 14.4 (36.6) (12.3) 8.5 (16.1) 0.1
Other Non-Cash Items 111.8 14.0 104.7 50.5 6.8 28.9 14.9 76.3 3.7 1.1
Operating Cash Flow (9.7) 24.2 (31.8) 50.5 111.4 24.7 41.9 (8.3) (66.1) (61.2)
Investing Activities
Capital Expenditure (19.9) (19.2) (26.8) (34.1) (23.5) (32.3) (19.5) (3.0) (5.7) (8.9)
Acquisitions 0 0 (69.5) (25.7) 0 0 0 1.7 0 (10.5)
Purchases of Investments (85.7) (264.3) (535.7) (467.7) (733.4) (497.1) (164.6) (123.6) 0 (30.6)
Sales/Maturities of Investments 257.1 306.5 546.2 569.5 570.0 233.3 127.2 35.8 8.5 50
Other Investing Activities (78.6) (46.4) 0 (8.9) (9.3) (4.9) 0 (1.7) 8.5 10.5
Investing Cash Flow 72.9 (23.5) (85.7) 33.2 (186.9) (296.1) (57.0) (90.7) 2.8 10.4
Financing Activities
Net Debt Issuance (40.8) 44.9 0 0 0 278.7 0 (87.7) 0 50.0
Stock Repurchased 0 (30) 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0.2 4.1 (0.7) 51.9 35.7 24.2 32.0 (8) 2.3
Financing Cash Flow (43.4) 8.4 4.1 16.9 51.9 314.4 24.2 117.2 32.4 52.3
Cash Position
Net Change in Cash 21.4 10.4 (113.6) 101.3 (23.4) 43.4 9.3 18.1 (31.0) 1.6
Cash at Beginning 69.2 58.9 172.5 71.2 94.6 51.2 41.8 23.7 44.7 43.1
Cash at End 90.6 69.2 58.9 172.5 71.2 94.6 51.2 41.8 13.7 44.7
Free Cash Flow (29.7) 5.0 (58.6) 16.4 87.8 (7.6) 22.4 (11.3) (71.9) (70.1)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Income Statement
Revenue 1,014.7 940.2 747.7 801.2 702.8 498.8 362.3 183.9 107.6 84.2 72.8 49.7 29.0 2.5 0
Gross Profit 530.8 489.6 367.7 413.0 376.2 260.5 194.2 89.8 44.1 23.6 26.6 15.2 6.2 (1.3) 0
Operating Income (78.1) (99.1) (233.2) (92.8) 22.7 (8.0) (16.7) (44.6) (62.9) (78.1) (69.0) (75.7) (49.4) (33.0) (24.2)
Net Income (204.7) (96.0) (222.6) (94.6) 15.6 (34.4) (24.8) (122.6) (73.0) (83.4) (72.4) (79.5) (63.1) (33.0) (25.5)
EPS (Diluted) -3.04 -1.47 -3.43 -1.47 0.24 -0.56 -0.42 -2.55 -12.86 -27.30 -25.04 -34.17 -27.53 -26.32 -20.34
Balance Sheet
Cash & Equivalents 90.6 69.2 58.9 172.5 71.2 94.6 51.2 41.8 13.7 44.7
Total Assets 881.1 967.7 952.7 1,052.8 905.1 716.4 326.1 206.3 95.3 112.4
Total Debt 444.5 473.6 415.7 419.9 314.7 228.3 20.4 0 76.5 79.0
Stockholders' Equity 155.2 263.1 313.6 439.9 433.1 366.3 195.0 131.3 (29.1) (5.9)
Cash Flow
Operating Cash Flow (9.7) 24.2 (31.8) 50.5 111.4 24.7 41.9 (8.3) (66.1) (61.2)
Capital Expenditure (19.9) (19.2) (26.8) (34.1) (23.5) (32.3) (19.5) (3.0) (5.7) (8.9)
Free Cash Flow (29.7) 5.0 (58.6) 16.4 87.8 (7.6) 22.4 (11.3) (71.9) (70.1)